1. Home
  2. SURG vs SER Comparison

SURG vs SER Comparison

Compare SURG & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SurgePays Inc.

SURG

SurgePays Inc.

HOLD

Current Price

$0.84

Market Cap

18.3M

ML Signal

HOLD

Logo Serina Therapeutics Inc.

SER

Serina Therapeutics Inc.

HOLD

Current Price

$1.46

Market Cap

19.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SURG
SER
Founded
2006
2017
Country
United States
United States
Employees
20
13
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.3M
19.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SURG
SER
Price
$0.84
$1.46
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$9.75
$13.00
AVG Volume (30 Days)
139.2K
65.2K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$3.78
$134.46
Revenue Next Year
$113.46
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.75
$1.42
52 Week High
$3.47
$7.92

Technical Indicators

Market Signals
Indicator
SURG
SER
Relative Strength Index (RSI) 41.12 34.91
Support Level $0.77 N/A
Resistance Level $0.95 $1.86
Average True Range (ATR) 0.07 0.12
MACD 0.03 0.02
Stochastic Oscillator 47.15 9.23

Price Performance

Historical Comparison
SURG
SER

About SURG SurgePays Inc.

Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; and Others. It generates the majority of its revenue from the Mobile Virtual Network Operators segment.

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.

Share on Social Networks: